Early Cancer Detection & Monitoring
Beyond primary site prediction, to diagnostics and monitoring
Oncocross is expanding the potential of early cancer detection, post-treatment monitoring, and clinical application based on blood-based biomarkers and multi-omics data analytics capabilities.
By precisely interpreting cancer-related molecular changes, we are advancing a data-driven diagnostics business that can support patient diagnosis and monitoring.
VALUE PROPOSITION
Application Value
-
Value Proposition 01
Multi-layered molecular analysis
Provides a structure for multi-layered analysis of molecular changes in cancer
-
Value Proposition 02
Early detection potential
Supports sophisticated interpretation of signals that are difficult to capture with conventional imaging-based approaches
-
Value Proposition 03
Post-treatment monitoring
Diverse clinical applications, including tracking post-treatment changes and monitoring signs of recurrence
BUSINESS SIGNIFICANCE
Business Significance
-
Point 01
Diagnostics Business Expansion Based on Core Technology Assets
Expanding early cancer detection and monitoring opportunities by leveraging ONCOfind AI®-based analytics capabilities
-
Point 02
Expansion into Diagnostics and Monitoring Markets
A business structure that can expand into early cancer detection and post-treatment monitoring
-
Point 03
Delivering Patient-Centered Clinical Value
Connecting data-driven analytics insights to real-world diagnostic and clinical decision support
COLLABORATION DIRECTION
Collaboration Direction
-
Collaboration in biomarker discovery and interpretation using clinical and multi-omics data
-
Molecular signal analysis for early cancer detection and post-treatment monitoring
-
Joint research and partnerships to validate diagnostic and clinical applicability
-
Flexible discussion on data analysis, application scope, and collaboration models based on partner needs
Together with Oncocross, we create new opportunities in drug discovery, diagnostics,
and data-driven expansion.
Let's Build the Next Possibility in Precision Medicine